NAVB Q3 Lymphoseek revenue projection 10/17/15 ver 1.1

Based on Q2 results and projections made in Q1, the sales for Q3 must be a significant beat, hopefully from the new NAVB' own sales force.  The probability is ...

Note that in Q2, Lymphoseek sales were lower than hoped, assuming a straight 28.7% sales projection.  Hopefully, for the bulls, the added sales rep will rectify this shortfall.

		Qtr 1 2014	Qtr 2 2014	Qtr 3 2014	Qtr 4 2014	Yr 2014	Qtr 1 2015	Qtr 2 2015	Qtr 3 2015
REVENUE
	Actual Lymphoseek Revenue	$626,631	$1,046,257	$1,101,071	$1,426,041	$4,200,000	$1,835,422	$1,963,548
	Projected Annual Lymphoseek revenue ($)	5-6M	5-6M	5-6M	4M	Lowered from 5-6M to 4M	10-12M for Yr 2015	?	?
	Lymphoseek revenue projection based on Q4 2014 to Q1 2015 growth rate					Q1 2015 to Q4 2014 increase	28.7%	$2,362,326	$3,040,491